Friday, 18 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14433
Articles
Company
Deals
Gaush Meditech IPOs on Hong Kong Stock Exchange at HKD 21.4 per Share
January 28, 2025
Company
Policy / Regulatory
Northeast Pharmaceutical Fined RMB 133M for Monopoly Selling
January 28, 2025
Company
Drug
Dizal Pharma Presents Golidocitinib Data at ASH Annual Meeting
January 28, 2025
Company
Deals
HitGen and Nitrase Therapeutics Enter Research Agreement
January 28, 2025
Company
Deals
Sequanta Technologies and Iomics Bio Collaborate on Multi-Omics Research
January 28, 2025
Company
Deals
Innoforce Partners with RNAimmune for mRNA Development and Production
January 28, 2025
Company
Medical Device
NMPA Approves COVID-19 Antigen Detection Reagents from Four Companies
January 28, 2025
Company
Deals
Biozon Partners with Agilent Technologies to Boost ICP-MS in China Clinics
January 28, 2025
Company
Drug
Sino Biopharmaceutical’s ATR Kinase Inhibitor TCC1727 Accepted for FDA Review
January 28, 2025
Company
Deals
Acotec Scientific and Boston Scientific Enter Acquisition and Collaboration Agreement
January 28, 2025
Company
Drug
Biogen’s Aducanumab Administered to Chinese Patient for First Time
January 28, 2025
Company
Drug
Stemirna Therapeutics’ COVID-19 mRNA Vaccine Gets EUA in Laos
January 28, 2025
1
2
…
1,073
1,074
1,075
1,076
1,077
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?